Product Information
BIMATOPROST 0.03% EYELASH SOLN is a generic product labeled by Sandoz Inc., priced at $26.2742 per ML under NDC 00781620693. Its NADAC has been published 472 times since Sep 20, 2017.
FDA first approved this application on Apr 19, 2016. Its Orange Book therapeutic-equivalence code is AT.
Strength
.3 mg/mL
Manufacturer
Sandoz Inc.NDC
00781620693
Classification
Generic
Dosage Form
SOLUTION/ DROPS
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
BIMATOPROSTApproval Type
Generic (ANDA)
FDA Application
ANDA202719FDA Approved
4/19/2016
TE Code
AT
On Market Since
12/6/2016
Pharmacological Classes
Price Statistics
The NADAC for BIMATOPROST 0.03% EYELASH SOLN has been published 472 times since Sep 20, 2017, and over the history we have for it it has declined 20.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $26.2742 per ML |
|---|---|
| All-time high | $36.6129 (Oct 10, 2018) |
| All-time low | $9.7099 (Nov 20, 2024) |
| 52-week high | $28.1666 |
| 52-week low | $25.6322 |
| Median price | $31.0427 |
| Average price | $30.1762 |
| Largest weekly change | +68.1% (Dec 18, 2024) |
| Weeks tracked | 472 |
| Tracking since | Sep 20, 2017 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 84% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sandoz Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Bimatoprost market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Prostaglandin Analog class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BIMATOPROST 0.03% EYELASH SOLN?
The current National Average Drug Acquisition Cost (NADAC) for BIMATOPROST 0.03% EYELASH SOLN, manufactured by Sandoz Inc., is $26.2742 per ML (NDC 00781620693), effective Sep 30, 2026.
How has the price of BIMATOPROST 0.03% EYELASH SOLN changed over time?
Over the history we have for it, the NADAC for BIMATOPROST 0.03% EYELASH SOLN has declined 20.3%. It has been tracked across 472 weekly CMS publications since Sep 20, 2017.
What are the highest and lowest recorded NADAC prices for BIMATOPROST 0.03% EYELASH SOLN?
Since Sep 20, 2017, the NADAC for BIMATOPROST 0.03% EYELASH SOLN has ranged from a low of $9.7099 (Nov 20, 2024) to a high of $36.6129 (Oct 10, 2018), with a median of $31.0427 per ML.
Are there cheaper alternatives to BIMATOPROST 0.03% EYELASH SOLN?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BIMATOPROST 0.03% EYE DROPS, is $4.2071 per ML — about 84% below BIMATOPROST 0.03% EYELASH SOLN.
Who manufactures BIMATOPROST 0.03% EYELASH SOLN?
BIMATOPROST 0.03% EYELASH SOLN (NDC 00781620693) is labeled by Sandoz Inc., and CMS classifies it as a generic product.